Vision and vision-related outcome measures in multiple sclerosis. - Wikidata - wikimedia - TriplyDB

Vision and vision-related outcome measures in multiple sclerosis.

Vision and vision-related outcome measures in multiple sclerosis.

http://www.wikidata.org/entity/Q30872452

about

Symptomatic management in multiple sclerosis Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder Outcome Measures in Clinical Trials for Multiple Sclerosis.Validity of low-contrast letter acuity as a visual performance outcome measure for multiple sclerosis.Introducing a new method to assess vision: Computer-adaptive contrast-sensitivity testing predicts visual functioning better than charts in multiple sclerosis patients.Blocking LINGO-1 in vivo reduces degeneration and enhances regeneration of the optic nerve.A conceptual model for vision rehabilitation.Identification of the flotillin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis Investigating Tissue Optical Properties and Texture Descriptors of the Retina in Patients with Multiple Sclerosis Delayed P100-Like Latencies in Multiple Sclerosis: A Preliminary Investigation Using Visual Evoked Spread Spectrum Analysis Quantifying visual pathway axonal and myelin loss in multiple sclerosis and neuromyelitis optica.Elevation of AQP4 and selective cytokines in experimental autoimmune encephalitis mice provides some potential biomarkers in optic neuritis and demyelinating diseases.Modeling the Chronic Loss of Optic Nerve Axons and the Effects on the Retinal Nerve Fiber Layer Structure in Primary Disorder of Myelin.Intranasal Delivery of A Novel Amnion Cell Secretome Prevents Neuronal Damage and Preserves Function In A Mouse Multiple Sclerosis Model.Pattern of gray matter volumes related to retinal thickness and its association with cognitive function in relapsing-remitting MS Diffusion MRI quantifies early axonal loss in the presence of nerve swelling.Functional connectivity alterations in a murine model of optic neuritis.A window to beyond the orbit: the value of optical coherence tomography in non-ocular disease.Justification for conducting neurological clinical trials as part of patient care within private practice.Neuroprotection by central nervous system remyelination: Molecular, cellular, and functional considerations.Length of optic nerve double inversion recovery hypersignal is associated with retinal axonal loss.Neuroprotection by eIF2α-CHOP inhibition and XBP-1 activation in EAE/optic neuritiss.Long-term structural retinal changes in patients with optic neuritis related to multiple sclerosis Diffusion tensor imaging for multilevel assessment of the visual pathway: possibilities for personalized outcome prediction in autoimmune disorders of the central nervous system.Quantitative visual tests after poorly recovered optic neuritis due to multiple sclerosis.Acute optic neuritis: a clinical paradigm for evaluation of neuroprotective and restorative strategies?Early retinal atrophy predicts long-term visual impairment after acute optic neuritis.The Contribution of Optical Coherence Tomography in Neuromyelitis Optica Spectrum Disorders.Anatomical Wiring and Functional Networking Changes in the Visual System Following Optic Neuritis.The Effect of In-School Saccadic Training on Reading Fluency and Comprehension in First and Second Grade Students.Perceptions on the value of bodily functions in multiple sclerosis.White matter tract-specific quantitative analysis in multiple sclerosis: Comparison of optic radiation reconstruction techniques.The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients.Phenytoin: its potential as neuroprotective and retinoprotective drug.[New aspects of symptomatic MS treatment: Part 4-sexual dysfunction and eye movement disorders].Mechanism of delayed conduction of fellow eyes in patients with optic neuritis.Myelin-oligodendrocyte-glycoprotein (MOG) autoantibodies as potential markers of severe optic neuritis and subclinical retinal axonal degeneration.Patients with multiple sclerosis demonstrate reduced subbasal corneal nerve fibre density.Vision Loss in a Teenage Girl With Postconcussion Syndrome.Retinal atrophy in relation to visual functioning and vision-related quality of life in patients with multiple sclerosis.

P2860

Q26779897-67247915-C584-4B78-82DE-CDB3B0F8FFD8 Q28076588-94A7DCAB-E127-4C03-AC94-18F87BA378AC Q31160866-DBF595BE-D52C-4CA3-B9C1-ACBDB696709D Q31162456-DCE3F2FD-8883-49BA-89C0-1B285B403B95 Q33692563-668BCCC8-AAEA-4153-8AA7-BC38BBC1DA0B Q33692583-8E676FED-53CC-40B4-B835-593240E2BCAB Q33727044-76DB7C0E-9EB0-4BF3-AC9E-E0799C6E087F Q33827241-2523D0A8-A3C7-4AFD-9F10-03A91486D60A Q35855972-4D46CD32-5676-40A4-9486-CF2194A7493E Q35883802-0FBBBDF1-74B4-4BD2-BB19-710C4D486C98 Q36058632-7F064AF1-5854-4463-96DC-4197FF843CDB Q36511714-A036FBCE-DBA9-4A02-9535-CB9D0212B7D4 Q37275299-1953A51B-DCA5-45F4-BCB4-8E1D8582734E Q37615358-FCDCAAA3-9FDC-4E9A-B89A-DB69560E4946 Q37653515-EA9844B2-4C2C-4A5F-951F-F62A52CF9E7F Q37741163-074D1C11-263A-4FFB-A373-F44521FC4365 Q38684135-A0B72547-C866-49F8-BF20-85A65A5B8789 Q38709464-EA18E41D-7869-4F28-ABBD-0AC24AF8AD71 Q38797002-4D06E64F-D1DF-465A-93D7-D9283287038A Q38952007-59694F64-A02D-405B-BBCF-3FC47378604F Q38979382-8160E95A-DFBF-4365-9A20-A5F87D056E06 Q41335521-CFFA7C9D-27FD-4C4C-9A44-410B7E3843C7 Q41484449-BC373C9A-8ED1-48C1-AD9A-1D03EF78B78A Q42361527-23AA8D4B-CFE6-485D-92A6-36BF19E6C990 Q43121362-24A49F26-58CA-4973-B5F5-92BD7375A163 Q43154346-0654EA13-C612-4AEA-BF5B-4C7591F7BF19 Q45151446-B0B7001E-9FE8-4533-9040-FFD955CA6CF7 Q47097507-6CDDAD9E-C2FC-4DCD-A860-561AF3BE6029 Q47216283-8D409596-28B8-4E2F-8A2E-9883D1079DC2 Q47426363-07EAE4D2-6632-4FB6-92BA-C4FC26D04E37 Q47567504-D9E3EC39-6620-451C-8CFE-6409DE905E64 Q47860010-28ACBDC0-A0DC-47FF-9463-46433AA09964 Q47975873-ABEF1368-AD8F-44A8-8A63-E9B110CAA7FC Q48193596-341D2A8B-9326-4250-9A16-68755990EE5F Q50100449-0CFEAD82-2EA9-4A17-8AB7-593C51D187C0 Q50331925-083227D3-6E30-4685-A901-5E284571B8CF Q51327401-F10ECA98-C11D-4D99-9CF8-50EF7CA98B66 Q52845476-E7489897-77E5-4248-8069-0C47D630E7C8 Q54581509-AA2DD67C-2F31-4475-9167-755139FBD5E2 Q54967864-7523C924-4B98-4100-93F8-9E7FA41DB53B

P2860

Vision and vision-related outcome measures in multiple sclerosis.

http://www.wikidata.org/entity/Q30872452

description

2014 nî lūn-bûn

@nan

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

2014年论文

@zh

2014年论文

@zh-cn

name

Vision and vision-related outcome measures in multiple sclerosis.

@ast

Vision and vision-related outcome measures in multiple sclerosis.

@en

type

label

Vision and vision-related outcome measures in multiple sclerosis.

@ast

Vision and vision-related outcome measures in multiple sclerosis.

@en

prefLabel

Vision and vision-related outcome measures in multiple sclerosis.

@ast

Vision and vision-related outcome measures in multiple sclerosis.

@en

P1433

Q30872452-B5903153-314F-4B28-8B33-B193DAB0DA9A

P1476

Q30872452-D2391B06-02FA-4C52-A9E9-E9CF61CD3A93

P2093

Q30872452-5B872C3E-E012-4BF1-8652-7D7302847BAF

Q30872452-80490E46-AE6F-4342-A793-D7B9D1552C3B

Q30872452-BB8E144B-98B2-4FA4-A192-F09E4938E354

P275

Q30872452-40C4CF3E-645E-48C4-B4ED-E41CC7D674EA

P2860

Q30872452-0086ADE9-BDDD-4C9A-A480-51CA821B9185

Q30872452-03E07D9F-DA7F-4F36-98E7-83B17AA6188D

Q30872452-07002897-1C6B-45FA-8225-592842CB1FD1

Q30872452-07C188E5-D19B-4456-8CC7-018CC6090E77

Q30872452-07D3F108-B9A4-49DC-8C6E-148343FACD82

Q30872452-07D8783F-2080-47FE-BDE6-5F2FDB8476B8

Q30872452-0829C192-25D2-45D0-BDBC-FBF8FCF32151

Q30872452-0910B634-943F-4A86-832E-A22A38FFF6DB

Q30872452-0A1F1A66-6468-4307-BFB3-E883B81D508E

Q30872452-0AB1FD50-EABE-4EC3-A231-CA5DBAB5B2E7

P304

Q30872452-BF2F3C10-E3EA-4384-B041-AA657B20AB86

P31

Q30872452-27E333E1-5CA8-4913-94F2-CE1B27BA15C6

Q30872452-35D7B342-296D-43EB-89EB-ABFFF9C39C0A

P356

Q30872452-B820E98F-A811-4854-B2A8-68BFF49BDE17

P407

Q30872452-9B9B57D9-5656-4084-8AB9-D3E9F2C05F49

P433

Q30872452-A83E2990-8831-43F9-A751-00B144819DE1

P478

Q30872452-801EFDEA-F855-467B-B106-0E8C6FD92974

P50

Q30872452-855967CD-B5AC-4F58-AB7E-76BF7B6166E3

P5008

Q30872452-25436014-B64D-489F-895E-1692A436C55F

P577

Q30872452-3B958513-7077-4ED3-850A-31DDFA69616A

Q30872452-53742E0D-5789-42F2-8CC8-E1D5D78098FB

P5875

Q30872452-84FD27C3-DE2D-4084-8214-C8194C028406

P698

Q30872452-25C5B1AD-3323-4233-88CD-B6D2AE61FD3B

P921

Q30872452-108526F5-C8C6-436D-96D6-90F68E561E91

Q30872452-AE371478-6D34-43F2-BEBB-931F5CE18211

P932

Q30872452-6CA1E7EA-3097-4F1D-B63F-1732E827DEC2

P356

P1433

P1476

Vision and vision-related outcome measures in multiple sclerosis.

@en

P2093

David H Miller

http://www.w3.org/2001/XMLSchema#string

Jeffrey A Cohen

http://www.w3.org/2001/XMLSchema#string

Stephen C Reingold

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial 4.0 License

P2860

Association of retinal and macular damage with brain atrophy in multiple sclerosis

Defining the clinical course of multiple sclerosis: the 2013 revisions.

Multiple sclerosis risk after optic neuritis: final optic neuritis treatment trial follow-up

Optical coherence tomography: a window into the mechanisms of multiple sclerosis

Mesenchymal stem cell transplantation in multiple sclerosis

A placebo-controlled trial of oral fingolimod in relapsing multiple sclerosis

Oral fingolimod or intramuscular interferon for relapsing multiple sclerosis

Optic nerve magnetisation transfer ratio after acute optic neuritis predicts axonal and visual outcomes.

Subretinal abscess causing restricted diffusion on magnetic resonance imaging.

Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire.

P304

11-27

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1093/BRAIN/AWU335

http://www.w3.org/2001/XMLSchema#string

P407

P433

Pt 1

http://www.w3.org/2001/XMLSchema#string

P478

138

http://www.w3.org/2001/XMLSchema#string

P50

P5008

P577

2014-11-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2015-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268987263

http://www.w3.org/2001/XMLSchema#string

P698

25433914

http://www.w3.org/2001/XMLSchema#string

P921

multiple sclerosis

P932

4285195

http://www.w3.org/2001/XMLSchema#string